XML 21 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-based compensation
9 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Stock-based compensation
Stock-based compensation
Under our 2009 Equity Incentive Plan, 2011 Stock Option and Grant Plan and 2019 Equity Incentive Plan, eligible employees, directors and consultants are able to participate in our future performance through awards of nonqualified stock options, incentive stock options and restricted stock units as authorized by our board of directors. In addition, we have granted restricted common stock in connection with certain acquisitions.
A summary of our stock option activity is as follows (in thousands except per share and contractual life amounts):
 
 

Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
(years)
 
Aggregate
Intrinsic
Value
Options outstanding as of June 30, 2019
 
3,409

 
$
6.49

 
 
 
 
Granted
 
55

 
4.92

 
 
 
 
Exercised
 
(1,343
)
 
6.27

 
 
 
 
Canceled or expired
 
(402
)
 
6.58

 
 
 
 
Options outstanding as of March 31, 2020
 
1,719

 
$
6.60

 
5.25
 
$

As of March 31, 2020:
 
 
 
 
 
 
 
 
Options vested and expected to vest
 
1,695

 
$
6.62

 
5.21
 
$

Options exercisable
 
1,442

 
$
6.86

 
4.76
 
$


A summary of our restricted stock unit, or RSU, activity is as follows (in thousands except contractual life amounts):
 
 
Number of
Shares
 
Weighted
Average
Remaining
Contractual 
Life
(years)
 
Aggregate
Intrinsic 
Value
RSUs outstanding as of June 30, 2019
 
2,637

 
 
 
 
Granted
 
1,584

 
 
 
 
Vested
 
(991
)
 
 
 
 
Canceled
 
(629
)
 
 
 
 
RSUs outstanding as of March 31, 2020
 
2,601

 
1.58
 
$
11,237

As of March 31, 2020:
 
 
 
 
 
 
RSUs expected to vest
 
2,232

 
1.47
 
$
9,643



Performance-based RSUs
In February 2020, the Compensation Committee of our board of directors (the “Compensation Committee”) approved the grant under our 2019 Equity Incentive Plan of performance-based RSUs covering a target of 500,000 shares of common stock under individual grants to certain of our executive officers, which we refer to as the 2020 PSU Awards. The 2020 PSU Awards are subject to four performance milestones, each requiring achievement of a specified trailing average closing stock price for a 30-trading day period on or before the three-year anniversary of the 2020 PSU Awards’ grant date. In the event our board of directors approves entering a transaction which, if consummated, would constitute a change in control of the Company, the performance milestones are increased with respect to shares not already eligible to vest under the 2020 PSU Award, and the performance period is extended to the four-year anniversary of the 2020 PSU Awards’ grant date. Achieving each individual stock price performance milestone will result in one quarter of the shares subject to the 2020 PSU Award becoming eligible to vest. If a stock price performance milestone is achieved, then the shares that became eligible to vest will vest in four (4) equal quarterly installments as of the ensuing March 10, June 10, September 10 and December 10 following the date of certification
of the date the performance milestone was achieved, in each case subject to the respective executive’s continued service with the Company through the applicable vesting date. Vesting under the 2020 PSU Award may be accelerated under certain conditions involving a change in control of our Company, including as provided under respective change in control agreements entered between us and the executive. The maximum number of shares subject to the 2020 PSU Award that may vest is 500,000. No shares had vested as of March 31, 2020 under the 2020 PSU Awards.
In September 2019, the Compensation Committee approved the grant under our 2009 Equity Incentive Plan of performance-based RSUs covering a target of 560,000 shares of common stock under individual grants to several of our executive officers, which we refer to as the 2019 PSU Awards. The 2019 PSU Awards are subject to four performance milestones, each requiring achievement of a specified trailing average closing stock price for a 30 trading day period on or before the three-year anniversary of the 2019 PSU Awards’ grant date. Achieving each individual stock price performance milestone will result in one quarter of the shares subject to the 2019 PSU Award becoming eligible to vest. If a stock price performance milestone is achieved, then one half of the shares that became eligible to vest under the 2019 PSU Award upon achievement of that stock price performance milestone will vest on the later of November 1, 2020, or the date that the Compensation Committee certifies achievement of the milestone, and the remaining one half of the shares that became eligible to vest will vest on the one-year anniversary of the date the performance milestone was achieved, in each case subject to the respective executive’s continued service with the Company through the applicable vesting date. The 2019 PSU Award milestones are subject to change upon a change in control, as defined in the agreement. The maximum number of shares subject to the 2019 PSU Award that may vest is 560,000. No shares had vested as of March 31, 2020 under the 2019 PSU Awards.
In October 2018, the Compensation Committee approved the grant under our 2009 Equity Incentive Plan of performance-based RSUs covering a target of 240,000 shares of common stock to Dr. HP Jin, our CEO, which we refer to as the CEO PSU Award. The CEO PSU Award is subject to four performance milestones, each requiring achievement of a specified trailing average closing stock price for a 30 trading day period on or before the three-year anniversary of the CEO PSU Award’s grant date. Achieving each individual stock price performance milestone will result in one quarter of the shares subject to the CEO PSU Award becoming eligible to vest. If a stock price performance milestone is achieved, then one half of the shares that became eligible to vest under the CEO PSU Award upon achievement of that stock price performance milestone will vest on the later of November 1, 2019, or the date that the Compensation Committee certifies achievement of the milestone, and the remaining one half of the shares that became eligible to vest will vest on the one-year anniversary of the date the performance milestone was achieved, in each case subject to Dr. Jin’s continued service with the Company through the applicable vesting date. The CEO PSU Award milestones are subject to change upon a change in control, as defined in the agreement. The maximum number of shares subject to the CEO PSU Award that may vest is 240,000. No shares had vested as of March 31, 2020 under the CEO PSU Award.
Since achievement of the awards is dependent on a market condition, stock-based compensation expense associated with these awards is recognized regardless of whether the market condition is satisfied, provided that the requisite service period has been met. We utilized the Monte Carlo valuation method to determine the fair value and derived service periods of each of the stock price performance milestones. Total stock-based compensation expense associated with all PSU Awards, included in the stock-based compensation expense table below, was $528,000 and $780,000 for the three and nine months ended March 31, 2020, and was not material for all prior periods presented.
As of March 31, 2020, no performance-based RSU awards had been earned or canceled, and 1,300,000 shares subject to performance-based RSU awards remained outstanding.
Shares available for grant
On July 1, 2019, pursuant to the annual increase provisions of our 2009 Equity Incentive Plan, or the 2009 Plan, the number of shares available for grant under this plan increased by 1,666,666 shares. This was the last annual increase in the shares reserved for issuance under our 2009 Plan, and the plan expired in October 2019 as to new awards. In September 2019, our board of directors also terminated the 2011 Stock Option and Grant Plan, or the 2011 Plan. In November 2019, our stockholders approved the 2019 Equity Incentive Plan, or the 2019 Plan, pursuant to which 5,700,000 shares are initially reserved for future grants and up to an additional 5,800,000 shares are reserved to the extent shares subject to grants under the 2009 Plan were outstanding as of November 20, 2019 but later expire or otherwise terminate without having been exercised in full (in which case the shares subject to such grants will be returned to the 2019 Plan and available for future issuance). The 2019 Plan became effective on November 20, 2019 and will automatically terminate 10 years from its date of adoption by our board of directors. In connection with the adoption of the 2019 Plan, a total of approximately 5,342,000 shares expired which had been previously available but unissued under the 2009 Plan and 2011 Plan. A summary of our shares available for grant activity is as follows (in thousands):
 
 
Number of
Shares
Shares available for grant as of June 30, 2019
 
4,472

Annual share increase authorized under 2009 Plan
 
1,667

Granted
 
(1,681
)
RSUs withheld for taxes in net share settlements
 
251

Canceled
 
633

Expired under 2009 and 2011 Plans
 
(5,342
)
Shares available under 2009 and 2011 Plans upon termination on November 20, 2019
 

Initial shares authorized under 2019 Plan on November 20, 2019
 
5,700

Shares added from 5,800,000 reserved share pool available(1) 
 
483

Granted
 
(1,019
)
Shares available for grant as of March 31, 2020
 
5,164

(1) Additional shares are available up to a maximum of 5,800,000 shares only to the extent shares subject to grants under the 2009 Plan were outstanding as of November 20, 2019 but later expire or otherwise terminate without having been exercised in full.

Employee Stock Purchase Plan
In November 2019, the Company’s stockholders approved the 2019 Employee Stock Purchase Plan, or ESPP, which became effective on November 20, 2019. A total of 2,500,000 shares were authorized for issuance to participating employees upon adoption of the ESPP. The ESPP provides for 12-month offering periods beginning March 1 and September 1 of each year, and each offering period will consist of two six-month purchase periods. The initial offering period commenced on March 1, 2020 and will end on March 1, 2021. On each purchase date, eligible employees will purchase the shares at a price per share equal to 85% of the lesser of (i) the fair market value of our stock on the enrollment date of the offering period or (ii) the fair market value of our stock on the exercise date.
Stock-based compensation expense
The following table summarizes the stock-based compensation expense for continuing operations recorded for stock options, RSUs, including performance-based RSUs, and ESPP purchase rights (in thousands):
 
 
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
 
2020
 
2019
 
2020
 
2019
Stock option awards
 
$
156

 
$
378

 
$
690

 
$
1,211

RSU awards
 
1,672

 
1,310

 
4,368

 
4,400

ESPP
 
131

 

 
131

 

Total stock-based compensation expense
 
$
1,959

 
$
1,688

 
$
5,189

 
$
5,611


We use valuation pricing models to determine the fair value of stock-based awards. The determination of the fair value of stock-based payment awards on the date of grant is affected by the stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the awards, actual and projected employee stock option exercise behaviors, risk-free interest rates and expected dividends. The weighted average assumptions used to value stock option awards granted and the resulting weighted average grant date fair value per share were as follows:
 
 
Nine Months Ended
March 31,
 
 
2020
 
2019
Expected volatility
 
48
%
 
39
%
Expected term (in years)
 
5.65

 
6.87

Risk-free interest rate
 
1.58
%
 
2.99
%
Dividend yield
 
%
 
%
Weighted average grant date fair value per share
 
$
2.27

 
$
2.32


No stock option awards were granted during the three months ended March 31, 2020 and 2019.

The weighted average assumptions used to value ESPP purchase rights during the initial offering period beginning March 1, 2020 were as follows:

Expected volatility
 
93
%
Expected term (in years)
 
0.75

Risk-free interest rate
 
0.92
%
Dividend yield
 
%